Pulsatile haemodynamic parameters are predictors of survival in paediatric pulmonary arterial hypertension

International Journal of Cardiology

Volumn 168, Issue 2, 2013, Pages 1370-1377

  Douwes, Johannes M ^a   Roofthooft, Marcus T R ^a   Bartelds, Beatrijs ^a   Talsma, Melle D ^a   Hillege, Hans L ^a   Berger, Rolf M F ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Cardiac catheterization; Haemodynamics; Paediatrics; Pulmonary hypertension; Survival analysis

Indexed keywords

ARTERIAL PRESSURE; ARTICLE; CHILD; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HEART CATHETERIZATION; HEART RATE; HEART STROKE VOLUME; HEMODYNAMIC PARAMETERS; HUMAN; LUNG ARTERY PRESSURE; LUNG CIRCULATION; LUNG COMPLIANCE; LUNG VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; SCHOOL CHILD; SURVIVAL; SURVIVAL PREDICTION; TRANSPLANT FREE SURVIVAL;

6-MINUTE WALK DISTANCE; 6-MWD; CARDIAC CATHETERIZATION; CARDIAC INDEX; CI; HAEMODYNAMICS; HAZARD RATIO; HR; IDIOPATHIC OR HEREDITARY PULMONARY ARTERIAL HYPERTENSION; IPAH/HPAH; MEAN PULMONARY ARTERIAL PRESSURE; MEAN RIGHT ATRIAL PRESSURE; MEAN SYSTEMIC ARTERIAL PRESSURE; MPAP; MRAP; MSAP; NITRIC OXIDE; NO; O2; OXYGEN; OXYGEN CONSUMPTION; PAC(I); PAEDIATRICS; PAH; PAH-CHD; PP; PSV(I); PULMONARY ARTERIAL COMPLIANCE (INDEX); PULMONARY ARTERIAL HYPERTENSION; PULMONARY ARTERIAL HYPERTENSION ASSOCIATED WITH CONGENITAL HEART DISEASE; PULMONARY FLOW INDEX; PULMONARY HYPERTENSION; PULMONARY STROKE VOLUME (INDEX); PULMONARY VASCULAR RESISTANCE (INDEX); PULSE PRESSURE; PVR(I); QPI; RIGHT VENTRICLE; RV; SURVIVAL ANALYSIS; VO(2); WHO-CLASS; WORLD HEALTH ORGANIZATION FUNCTIONAL CLASS;

ADOLESCENT; BLOOD FLOW VELOCITY; CHILD; CHILD, PRESCHOOL; FEMALE; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; MALE; PREDICTIVE VALUE OF TESTS; PULSATILE FLOW; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84885306496     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.12.080     Document Type: Article

References (31)

1. Berger RM, Bonnet D. Treatment options for paediatric pulmonary arterial hypertension. Eur Respir Rev 2010;19:321-30.
2. Authors/Task Force Members, Galie N, Hoeper MM, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009;30:2493-537.
3. Hoeper MM, Markevych I, Spiekerkoetter E, Welte T, Niedermeyer J. Goal-oriented treatment and combination therapy for pulmonary arterial hypertension. Eur Respir J 2005;26:858-63.
4. D'Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 1991;115:343-9.
5. Sitbon O, Humbert M, Nunes H, et al. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. J Am Coll Cardiol 2002;40:780-8.
6. Channick RN, Simonneau G, Sitbon O, et al. Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study. Lancet 2001;358:1119-23.
7. Miyamoto S, Nagaya N, Satoh T, et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med 2000;161:487-92.
8. Berger RM, Beghetti M, Humpl T, et al. Clinical features of paediatric pulmonary hypertension: a registry study. Lancet 2012;379:537-46.
9. Hoeper MM, Oudiz RJ, Peacock A, et al. End points and clinical trial designs in pulmonary arterial hypertension: clinical and regulatory perspectives. J Am Coll Cardiol 2004;43:48S-55S.
10. McLaughlin VV, Shillington A, Rich S. Survival in primary pulmonary hypertension: the impact of epoprostenol therapy. Circulation 2002;106:1477-82.
11. Moledina S, Hislop AA, Foster H, Schulze-Neick I, Haworth SG. Childhood idiopathic pulmonary arterial hypertension: a national cohort study. Heart 2010;96: 1401-6.
12. Barst RJ, McGoon MD, Elliott CG, Foreman AJ, Miller DP, Ivy DD. Survival in childhood pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management. Circulation 2012;125:113-22.
13. van Loon RL, Roofthooft MT, Delhaas T, et al. Outcome of pediatric patients with pulmonary arterial hypertension in the era of new medical therapies. Am J Cardiol 2010;106:117-24.
14. Ivy DD, Rosenzweig EB, Lemarie JC, Brand M, Rosenberg D, Barst RJ. Long-term outcomes in children with pulmonary arterial hypertension treated with bosentan in real-world clinical settings. Am J Cardiol 2010;106:1332-8.
15. Lankhaar JW, Westerhof N, Faes TJ, et al. Quantification of right ventricular afterload in patients with and without pulmonary hypertension. Am J Physiol Heart Circ Physiol 2006;291:H1731-7.
16. Sniderman AD, Fitchett DH. Vasodilators and pulmonary arterial hypertension: the paradox of therapeutic success and clinical failure. Int J Cardiol 1988;20: 173-81.
17. Wang Z, Chesler NC. Pulmonary vascular wall stiffness: an important contributor to the increased right ventricular afterload with pulmonary hypertension. Pulm Circ 2011;1:212-23.
18. Mahapatra S, Nishimura RA, Oh JK, McGoon MD. The prognostic value of pulmonary vascular capacitance determined by Doppler echocardiography in patients with pulmonary arterial hypertension. J Am Soc Echocardiogr 2006;19:1045-50.
19. Mahapatra S, Nishimura RA, Sorajja P, Cha S, McGoon MD. Relationship of pulmonary arterial capacitance and mortality in idiopathic pulmonary arterial hypertension. J Am Coll Cardiol 2006;47:799-803.
20. van Wolferen SA, Marcus JT, Boonstra A, et al. Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension. Eur Heart J 2007;28:1250-7.
21. Gan CT, Lankhaar JW, Westerhof N, et al. Noninvasively assessed pulmonary artery stiffness predicts mortality in pulmonary arterial hypertension. Chest 2007;132:1906-12.
22. Berger RM, Cromme-Dijkhuis AH, HopWC, KruitMN, Hess J. Pulmonary arterial wall distensibility assessed by intravascular ultrasound in children with congenital heart disease: an indicator for pulmonary vascular disease? Chest 2002;122:549-57.
23. Friedberg MK, Feinstein JA, Rosenthal DN. Noninvasive assessment of pulmonary arterial capacitance by echocardiography. J Am Soc Echocardiogr 2007;20: 186-90.
24. Hunter KS, Lee PF, Lanning CJ, et al. Pulmonary vascular input impedance is a combined measure of pulmonary vascular resistance and stiffness and predicts clinical outcomes better than pulmonary vascular resistance alone in pediatric patients with pulmonary hypertension. Am Heart J 2008;155:166-74.
25. LaFarge CG, Miettinen OS. The estimation of oxygen consumption. Cardiovasc Res 1970;4:23-30.
26. Krovetz LJ, Goldbloom S. Normal standards for cardiovascular data. I. Examination of the validity of cardiac index. Johns Hopkins Med J 1972;130:174-86.
27. Chemla D, Castelain V, Herve P, Lecarpentier Y, Brimioulle S. Haemodynamic evaluation of pulmonary hypertension. Eur Respir J 2002;20:1314-31.
28. Sajan I, Manlhiot C, Reyes J, McCrindle BW, Humpl T, Friedberg MK. Pulmonary arterial capacitance in children with idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease: relation to pulmonary vascular resistance, exercise capacity, and survival. Am Heart J 2011;162:562-8.
29. Douwes JM, van Loon RL, Hoendermis ES, et al. Acute pulmonary vasodilator response in paediatric and adult pulmonary arterial hypertension: occurrence and prognostic value when comparing three response criteria. Eur Heart J 2011;32:3137-46.
30. Benza RL, Miller DP, Gomberg-Maitland M, et al. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL). Circulation 2010;122:164-72.
31. Henkens IR, Van Wolferen SA, Gan CT, et al. Relation of resting heart rate to prognosis in patients with idiopathic pulmonary arterial hypertension. Am J Cardiol 2009;103:1451-6.